We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For manufacturers reporting adverse incidents with neurostimulators under the vigilance system.
To celebrate International Women’s Day 2023, some of our colleagues have shared their passion for STEM.
£500k is available to fund the development of novel PoC diagnostics devices.
Types of ingredients permitted in nicotine-containing liquids in electronic cigarettes and refill containers.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2020.
Guidance for clinical trials that use Decentralised Manufactured Investigational Medicinal Products (IMPs).
To share a common understanding of the objectives and the operations of the Access Consortium - Generic Medicines Working Group (GMWG).
Submitting annual reports on sales of electronic cigarettes and refill containers.
Information to raise awareness with commissioners and providers of the community pharmacy offer for sexual health, reproductive health and HIV services.
General advice on due diligence - electronic cigarettes devices and refill containers.
Briefing for local authorities on the increasing role of community pharmacy in public health, working with councils and other community partners.
Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition
Guidance on labelling requirements pertinent to the type of medicinal product and its supply status, as defined in UK legislation.
How the MHRA assesses marketing authorisation applications (MAA) for medicines referred under Article 29.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore the Non-Compressible Haemorrhage (NCH) environment. To understand who is doing work in this area and possible novel solutions of treatmen…
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system.
How to test and report levels of nicotine uptake when submitting a notification of intent to market e-cigarette and vape products.
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
A unique initiative which aims to accelerate the time to patient care for transformative medicines and medicine-device combinations.
Instructions for integrating with the new production MORE platform API.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).